Skip to main content

Telomir Pharmaceuticals, Inc.

TELO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001971532

No open-market purchases or sales by Telomir Pharmaceuticals, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $3.80M in total; no superinvestor holds it.

13F holders, Q1 2024

Institutional positions in Telomir Pharmaceuticals, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
7
+7 vs. Q4 2023
Shares held
79.9K
+79.9K vs. Q4 2023
Total value
$413.5K
+$413.5K vs. Q4 2023
New holders
7
0 more added
Sold out
0
0 more reduced

Compare with Q4 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TELO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2024: 7 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 7 institutionsQ2 2024: 25 institutionsQ3 2024: 34 institutionsQ4 2024: 39 institutionsQ1 2025: 42 institutionsQ2 2025: 43 institutionsQ3 2025: 32 institutionsQ4 2025: 33 institutionsQ1 2026: 27 institutionsQ2 2026: 33 institutions
Value heldQ1 2024: $413.5K
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $413.5KQ2 2024: $1.74MQ3 2024: $13.1MQ4 2024: $14.7MQ1 2025: $11.9MQ2 2025: $3.51MQ3 2025: $3.24MQ4 2025: $3.04MQ1 2026: $2.91MQ2 2026: $3.80M
Institutions holding TELO and their total value by quarter
QuarterHoldersValue
Q2 202633$3.80M
Q1 202627$2.91M
Q4 202533$3.04M
Q3 202532$3.24M
Q2 202543$3.51M
Q1 202542$11.9M
Q4 202439$14.7M
Q3 202434$13.1M
Q2 202425$1.74M
Q1 20247$413.5K
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q1 2024

Shares, value and share of portfolio for each institution holding Telomir Pharmaceuticals, Inc.; share changes are against Q4 2023.

Institutions holding TELO in Q1 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Suncoast Equity Management24,391$125.6K0.01%+24,391New
Citigroup Inc17,748$92.8K0.00%+17,748New
Lido Advisors, LLC15,000$77.3K0.00%+15,000New
FNY Investment Advisers, LLC14,900$77.0K0.05%+14,900New
Beaird Harris Wealth Management, LLC4,673$24.1K0.00%+4,673New
JPMorgan Chase & Co2,605$13.6K0.00%+2,605New
Advisor Group Holdings, Inc.600$3.09K0.00%+600New